These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38231053)

  • 41. Recurrent diffuse tenosynovial giant cell tumor of the knee treated with adjuvant radiotherapy: A case report.
    Lubis AMT; Sahala MA
    Int J Surg Case Rep; 2023 Sep; 110():108604. PubMed ID: 37591190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CORR Insights®: What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?
    Bus M
    Clin Orthop Relat Res; 2024 Jul; 482(7):1230-1231. PubMed ID: 38251962
    [No Abstract]   [Full Text] [Related]  

  • 43. Synovial hemangioma presenting with chronic painful infrapatellar mass: a case report.
    Suphakitchanusan W; Wongboonkuakul N; Trakulsujaritchok K; Decha-Umphai C; Chobpenthai T
    BMC Musculoskelet Disord; 2024 Jul; 25(1):584. PubMed ID: 39054426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic resection of a localized tenosynovial giant cell tumor causing posterior ankle impingement in a 15-year-old athlete: A case report.
    Yıldırım K; Beyzadeoğlu TB; Pehlivanoğlu T
    Jt Dis Relat Surg; 2021; 32(1):234-238. PubMed ID: 33463443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
    Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
    Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
    Mastboom MJL; Staals EL; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Palmerini E; Schaap GR; Jutte PC; Aston W; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; van de Sande MAJ;
    J Bone Joint Surg Am; 2019 Jul; 101(14):1309-1318. PubMed ID: 31318811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection (
    Marshall JH; Skedros JG; Campana CF; Seibert AM
    Case Rep Infect Dis; 2021; 2021():5523212. PubMed ID: 34557317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.
    Takeuchi A; Nomura A; Yamamoto N; Hayashi K; Igarashi K; Tandai S; Kawai A; Matsumine A; Miwa S; Nishida Y; Nakamura T; Terauchi R; Hoshi M; Kunisada T; Endo M; Yoshimura K; Murayama T; Tsuchiya H
    BMC Musculoskelet Disord; 2019 Feb; 20(1):68. PubMed ID: 30738433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arthroscopic Excision of Tendinous Giant Cell Tumors Causing Locking in the Knee Joint.
    Gülenç B; Kuyucu E; Yalçin S; Çakir A; Bülbül AM
    Acta Chir Orthop Traumatol Cech; 2018; 85(2):109-112. PubMed ID: 30295596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical spine tenosynovial giant cell tumor involving the atlantoaxial joint in a pediatric patient with medulloblastoma.
    Tsui WWC; Fung KFK; Chan PKJ; Yuen MKE; Kan YLE
    Skeletal Radiol; 2022 Jun; 51(6):1317-1324. PubMed ID: 34773486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric Tenosynovial Giant Cell Tumor of the Flexor Hallucis Longus Tendon Sheath: A Case Report.
    Williams RD; Honeycutt MW; Manci EA; Nimityongskul P
    JBJS Case Connect; 2020; 10(2):e0519. PubMed ID: 32649117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tenosynovial giant cell tumor arising from the posterior cruciate ligament: a case report and literature review.
    Xu Z; Mao P; Chen D; Shi D; Dai J; Yao Y; Jiang Q
    Int J Clin Exp Pathol; 2015; 8(6):6835-40. PubMed ID: 26261570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localized nodular synovitis of the knee: MR imaging appearance and clinical correlates in 21 patients.
    Huang GS; Lee CH; Chan WP; Chen CY; Yu JS; Resnick D
    AJR Am J Roentgenol; 2003 Aug; 181(2):539-43. PubMed ID: 12876042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
    Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
    BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CT.
    Mastboom MJL; Lips W; van Langevelde K; Mifsud M; Ng C; McCarthy CL; Athanasou NA; Gibbons CLMH; van de Sande MAJ
    Surg Oncol; 2020 Dec; 35():261-267. PubMed ID: 32932224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
    Bernthal NM; Healey JH; Palmerini E; Bauer S; Schreuder H; Leithner A; Martin-Broto J; Gouin F; Lopez-Bastida J; Gelderblom H; Staals EL; Burke ZD; Geiger EJ; Spierenburg G; Laeis P; Beyerlein E; Ye X; van de Sande M
    J Surg Oncol; 2022 Dec; 126(8):1520-1532. PubMed ID: 36006054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.